In the I-PRESERVE trial, patients with age ≥75 years, NT-proBNP ≥339 pg/mL, presence of diabetes mellitus, previous hospitalization for HF and NYHA class IV showed a significant increase in event rate, including SCD. This evidence concerns the gene NPPB and Schnyder corneal dystrophy.